Photodynamic therapy, abbreviated to FDT or PDT (photodynamic therapy) in English, is a medical treatment that was primarily used for wet age-related macular degeneration. In this form of macular degeneration, abnormal blood vessels grow beneath the retina; these can leak and thus impair central vision.
The treatment takes place in two stages. First, a light-sensitive substance, usually verteporfin, is administered via a drip. This substance attaches itself to the walls of the abnormal blood vessels in the eye. After a waiting period of around fifteen minutes, the ophthalmologist directs a special, non-thermal laser at the affected area of the macula. The laser light activates the light-sensitive substance, triggering a reaction that can cause the abnormal blood vessels to close.
FDT was mainly used between 2000 and 2010. Nowadays, the treatment is used less frequently, as other treatments have since become available, such as anti-VEGF injections, which are considered more effective for many patients with wet age-related macular degeneration. In certain specific situations, however, FDT may still be considered.
After treatment, you will be temporarily more sensitive to light, as the light-sensitive substance is still present in your body. You are therefore advised to avoid direct sunlight and bright artificial light for a few days.